The Motley Fool
26 Jul 2026, 09:47 UTC · 4h ago
Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
The Motley Fool
26 Jul 2026, 09:47 UTC · 4h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
AbbVie has agreed to acquire Apogee Therapeutics for $10.9 billion to obtain the eczema drug zumilokibart. — Strategic acquisitions of promising drugs typically expand a pharmaceutical company's long-term revenue pipeline and market share.
+0.40Johnson & Johnson reported second-quarter revenue growth of 6.6% year-over-year, totaling $25 billion. — Strong top-line growth in a diversified healthcare giant signals operational health and demand for its medical products.
+0.30AbbVie's forward P/E ratio of 18 and Johnson & Johnson's forward P/E of 22 are both significantly above their respective five-year averages. — Trading at a premium to historical averages suggests the stocks may be overvalued, potentially limiting short-term upside.
-0.20Which stocks this story touches
Continue reading
6 related stories
Search tags
The company has a deep pipeline, a promising weight-loss formulation, and a strategic acquisition of Apogee Therapeutics, though it is noted as slightly overvalued.
The company reported strong second-quarter revenue growth and a robust portfolio of billion-dollar products, despite being described as overvalued.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
Seeking Alpha
1h ago
